Klaus Eisendle

Summary

Affiliation: Innsbruck Medical University
Country: Austria

Publications

  1. ncbi The expanding spectrum of cutaneous borreliosis
    K Eisendle
    Department of Dermatology and Venerology, Innsbruck Medical University, Innsbruck, Austria
    G Ital Dermatol Venereol 144:157-71. 2009
  2. ncbi Possible role of Borrelia burgdorferi sensu lato infection in lichen sclerosus
    Klaus Eisendle
    Department of Dermatology and Venerology, Innsbruck Medical University, Anichstr 35, 6020 Innsbruck, Austria
    Arch Dermatol 144:591-8. 2008
  3. ncbi Focus floating microscopy: "gold standard" for cutaneous borreliosis?
    Klaus Eisendle
    Department of Dermatology and Venerology, Innsbruck Medical University, Innsbruck, Austria
    Am J Clin Pathol 127:213-22. 2007
  4. ncbi Overexpression of the chemokine receptors CXCR4, CCR7, CCR9, and CCR10 in human primary cutaneous melanoma: a potential prognostic value for CCR7 and CCR10?
    Laura Kühnelt-Leddihn
    Department of Dermatology, Medical University Innsbruck, Innsbruck, Austria
    Arch Dermatol Res 304:185-93. 2012
  5. ncbi High prevalence of 'Borrelia-like' organisms in skin biopsies of sarcoidosis patients from Western Austria
    Anna Maria Derler
    Department of Dermatology and Venereology, Innsbruck Medical University, Innsbruck, Austria
    J Cutan Pathol 36:1262-8. 2009
  6. ncbi Detection of spirochetal micro-organisms by focus-floating microscopy in necrobiotic xanthogranuloma
    Bernhard Zelger
    Department of Dermatology and Venerology, Innsbruck Medical University, Innsbruck, Austria
    J Am Acad Dermatol 57:1026-30. 2007
  7. ncbi Pruritus of unknown origin and elevated total serum bile acid levels in patients without clinically apparent liver disease
    Klaus Eisendle
    Department of Dermatology and Venerology, Medical University Innsbruck, Innsbruck, Austria
    J Gastroenterol Hepatol 26:716-21. 2011
  8. ncbi Infliximab monotherapy as first-line treatment for adult-onset pityriasis rubra pilaris: case report and review of the literature on biologic therapy
    Hansgeorg Muller
    Department of Dermatology and Venerology, Innsbruck Medical University, Innsbruck, Austria
    J Am Acad Dermatol 59:S65-70. 2008
  9. ncbi Phenotypic and functional deficiencies of leukaemic dendritic cells from patients with chronic myeloid leukaemia
    Klaus Eisendle
    Laboratory for Tumour and Immunobiology, Division of Haematology and Oncology, Innsbruck University Hospital, Innsbruck, Austria
    Br J Haematol 120:63-73. 2003
  10. ncbi Effect of the dual endothelin receptor antagonist bosentan on Raynaud's phenomenon secondary to systemic sclerosis: a double-blind prospective, randomized, placebo-controlled pilot study
    Van Anh Nguyen
    Department of Dermatology, Innsbruck Medical University, Anichstrasse 35, A 6020 Innsbruck, Austria
    Rheumatology (Oxford) 49:583-7. 2010

Collaborators

Detail Information

Publications10

  1. ncbi The expanding spectrum of cutaneous borreliosis
    K Eisendle
    Department of Dermatology and Venerology, Innsbruck Medical University, Innsbruck, Austria
    G Ital Dermatol Venereol 144:157-71. 2009
    ....
  2. ncbi Possible role of Borrelia burgdorferi sensu lato infection in lichen sclerosus
    Klaus Eisendle
    Department of Dermatology and Venerology, Innsbruck Medical University, Anichstr 35, 6020 Innsbruck, Austria
    Arch Dermatol 144:591-8. 2008
    ..To assess the evidence for Borrelia burgdorferi sensu lato infection in patients with lichen sclerosus by focus-floating microscopy...
  3. ncbi Focus floating microscopy: "gold standard" for cutaneous borreliosis?
    Klaus Eisendle
    Department of Dermatology and Venerology, Innsbruck Medical University, Innsbruck, Austria
    Am J Clin Pathol 127:213-22. 2007
    ..4% vs 100%). All 169 control cases, except 1 false-positive case of secondary syphilis, were negative with FFM. FFM is an easy, quick, and inexpensive method to reliably detect Borrelia in cutaneous tissue sections...
  4. ncbi Overexpression of the chemokine receptors CXCR4, CCR7, CCR9, and CCR10 in human primary cutaneous melanoma: a potential prognostic value for CCR7 and CCR10?
    Laura Kühnelt-Leddihn
    Department of Dermatology, Medical University Innsbruck, Innsbruck, Austria
    Arch Dermatol Res 304:185-93. 2012
    ....
  5. ncbi High prevalence of 'Borrelia-like' organisms in skin biopsies of sarcoidosis patients from Western Austria
    Anna Maria Derler
    Department of Dermatology and Venereology, Innsbruck Medical University, Innsbruck, Austria
    J Cutan Pathol 36:1262-8. 2009
    ..Sarcoidosis is a multisystem granulomatous disorder of unknown aetiology with frequent skin involvement...
  6. ncbi Detection of spirochetal micro-organisms by focus-floating microscopy in necrobiotic xanthogranuloma
    Bernhard Zelger
    Department of Dermatology and Venerology, Innsbruck Medical University, Innsbruck, Austria
    J Am Acad Dermatol 57:1026-30. 2007
    ..Necrobiotic xanthogranuloma (NXG) is a rare histiocytic disorder of unknown origin...
  7. ncbi Pruritus of unknown origin and elevated total serum bile acid levels in patients without clinically apparent liver disease
    Klaus Eisendle
    Department of Dermatology and Venerology, Medical University Innsbruck, Innsbruck, Austria
    J Gastroenterol Hepatol 26:716-21. 2011
    ..Our aim in the present study was to investigate the role of elevated TSBA levels in patients with PUO and the efficacy of ursodeoxycholic acid (UDCA) and cholestyramine therapy...
  8. ncbi Infliximab monotherapy as first-line treatment for adult-onset pityriasis rubra pilaris: case report and review of the literature on biologic therapy
    Hansgeorg Muller
    Department of Dermatology and Venerology, Innsbruck Medical University, Innsbruck, Austria
    J Am Acad Dermatol 59:S65-70. 2008
    ..Further studies are warranted to evaluate possible differences in efficacy among the different biologics...
  9. ncbi Phenotypic and functional deficiencies of leukaemic dendritic cells from patients with chronic myeloid leukaemia
    Klaus Eisendle
    Laboratory for Tumour and Immunobiology, Division of Haematology and Oncology, Innsbruck University Hospital, Innsbruck, Austria
    Br J Haematol 120:63-73. 2003
    ..Thus, TNF-alpha alone or in combination with pro-inflammatory and T-cell stimulatory cytokines should be considered as an adjuvant for DC-based immunotherapy in CML...
  10. ncbi Effect of the dual endothelin receptor antagonist bosentan on Raynaud's phenomenon secondary to systemic sclerosis: a double-blind prospective, randomized, placebo-controlled pilot study
    Van Anh Nguyen
    Department of Dermatology, Innsbruck Medical University, Anichstrasse 35, A 6020 Innsbruck, Austria
    Rheumatology (Oxford) 49:583-7. 2010
    ..To investigate the efficacy of the endothelin receptor antagonist, bosentan, in patients with RP secondary to SSc without pre-existing digital ulcers...